Summary
Datura metel L. is a medicinal herb that contains withasteroids and has a wide range of biological activities. We isolated seven withasteroids from the flowers of D. metel L and examined their ability to inhibit immune responses in vitro and in vivo. Among the withasteroids, withasteroid B2 exhibited the strongest inhibitory effect on immune responses comparing B2 with other isolated compounds from D. metel L., including suppressing the differentiation of CD4
1 T cells by inhibiting the expression and production of T cell lineage-specific master regulators and cytokines and directly suppressing the cytokine-induced Janus kinase/signal transducer and activator of transcription (JAK/STAT) signalling pathways. In the interleukin (IL)-23-induced mouse ear model of skin disease, B2 repressed disease development by inhibiting the expression of proinflammatory mediators in murine ear skin. Moreover, B2 affected the maturation of dendritic cells (DCs) in vitro which, in turn, induced T cell differentiation with an increased regulatory T cell (T reg ) phenotype and decreased T helper type 17 (Th17) phenotype. This study provides new evidence that B2 might ameliorate chronic inflammatory skin diseases by suppressing pathogenic CD4 1 T cell differentiation and the IL-17 
Introduction
Psoriasis is a complex, chronic, immune-mediated inflammatory skin disorder that affects 2-3% of the population. Psoriasis is characterized by thickening, scaling or erythema in the skin, and results from the dysregulation of epidermal keratinocytes and inflammatory infiltration of leucocytes that release growth factors, cytokines and chemokines [1] . Although the pathogenic mechanism of psoriasis remains unclear, it is believed to be a chronic inflammatory autoimmune disease that is mediated by T cells, particularly T helper type 1 (Th1) and Th17 cells. Accumulating evidence suggests that many innate and adaptive immune cells, including Th1 cells, and Th17-derived cytokines, such as tumour necrosis factor (TNF-a), interleukin (IL)-6, IL-1b, IL-17A, IL-22 and IL-23, are involved in and interact as a network in the pathogenesis of psoriasis [2] [3] [4] [5] [6] [7] . The proinflammatory cytokines are found in psoriatic lesions and peripheral blood [8] . Moreover, some studies have shown that impaired regulatory T cell (T reg ) functions in psoriasis patients contribute to the development of allergic inflammatory skin diseases, such as psoriasis [9, 10] . Th17 cells are involved critically in the pathology of psoriasis. Consequently, retinoic-acidreceptor-related orphan receptor gamma t (RORgt) 1 IL-
Th17 responses must be regulated tightly in vivo to mediate effective host defences against pathogens without causing excessive host tissue damage. CD4
1 CD25 high fork-effector T helper cell subsets, and psoriasis has also been associated with an impaired suppressive capacity of T regs [11] . Although Th17 and T reg cells represent two CD4 1 T cell subsets with opposing principal functions, these cell types are functionally connected [12] . An imbalance of Th17 and T reg cells is involved in many autoimmune, inflammatory and allergic reactions, such as psoriasis. The recovery of these cells is thought to play an important role in the prevention and treatment of psoriasis. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is the major signalling pathway involved in the differentiation and function of CD4 1 T cells and is triggered by cytokines [13] [14] [15] [16] . The JAK/ STAT pathway plays a critical role in the activation of transcription factors that induce lineage-specific master transcription factors, including T-box transcription factor TBX21 (T-bet), GATA-binding protein 3 (GATA-3), RORgt and FoxP3, during CD4
1 T cell differentiation [15] [16] [17] .
STAT-1 and STAT-4 are critical for Th1 cell differentiation, whereas STAT-5 and STAT-6, STAT-3 and STAT-5 are critical for Th2, Th17 and T reg cell differentiation, respectively. These STAT proteins also collaborate with the master transcription factors to induce cytokine production by CD4 1 T cells [13, 15, 16] . Recently, the JAK protein has emerged as a possible new therapeutic target for the treatment of autoimmune inflammatory diseases, including psoriasis [18, 19] . Several JAK inhibitors are being tested in clinical and preclinical trials with promising results. Additionally, total STAT-3 expression has also been shown to be up-regulated in psoriatic lesions, and a transgenic mouse model that constitutively over-expresses activated STAT-3 in the basal stem-cell layer of the epidermis is able to reproduce many of the characteristic features of psoriasis [20, 21] . Withasteroids are a group of structurally diverse steroidal compounds with a C28 steroidal lactone skeleton, in which a characteristic feature is the presence of an a,bunsaturated d lactone ring in the side chain; withasteroids are observed primarily in several genera of Solanaceae. In recent years, withanolides have received considerable attention because of their versatile biological activities, such as anti-tumour [22] , cytotoxic [23, 24] , anti-inflammatory [25, 26] , immunosuppressive [23] and chemoprevention activities [27] . Datura metel L. (baimantuoluo in Chinese), shown in Fig. 1a , is an annual herb that belongs to the Solanaceae family. The flower of D. metel L. is a traditional Chinese medicine and is listed officially in the Chinese Pharmacopoeia [28] .
D. metel L. has been used in Chinese folk medicine for centuries for the treatment of asthma, cough, convulsions, pain, rheumatism, convulsion and insanity [29] . Professor Gang Liu, Doctor of Heilongjiang University of Traditional Chinese Medicine, discovered the perfect anti-psoriasis effect of D. metel accidentally in clinical practice.
Chemical investigations have shown that withanolides are the main constituents of the effective part of D. metel flowers for psoriasis treatment, and a series of withanolides has been isolated [30] [31] [32] [33] [34] [35] [36] . However, the active constituents and pharmacological effects of D. metel flowers for the treatment of psoriasis have not been elucidated fully. As part of a continuing project to study the active constituents of Flos Daturae for psoriasis [31, 33, 36] 
Materials and methods

Experimental animals
The experimental protocols for the animal studies were approved by the Catholic 
Induction of disease
Skin lesions were induced in mice through an intradermal injections into the left ear of 0Á5 mg of mouse IL-23 (eBioscience) in 20 ml of phosphate-buffered saline (PBS) on days 0, 2, 4, 6, 8, 10, 12 and 14. The IL-23-injected mice were treated orally with B2 on days 3, 6, 9, 12 and 15. One group of IL-23-injected mice was treated with a control oligonucleotide at a dose of 15 mg/kg, and another group of mice was treated with PBS using the same dosing schedule as was used for the antagonist. The IL-23-induced increase in ear thickness was monitored using a Peacock dial thickness gauge, and ear samples were collected on day 18. Lesions were induced on the dorsal skin through daily intradermal injections of IL-23 (1 mg) from days 0 to 3. The IL-23-treated mice were treated orally at a distal site with B2, control or PBS on days 3, 4 and 5. All the mice were killed on day 6, and samples were collected for evaluation.
Isolation and purification of B2 ]-NMR spectrum. This multiplicity was characteristic of a 12a-hydroxy-withanolide. Therefore, B2 was elucidated as (5a, 5a, a, 22R)-5,12-dihydroxy-1,26-dioxo-6,7; 22,26-diepoxyerosta-2,24-dien-27-yl b-D-glucopyranoside.
Cell isolation and culture
Peripheral blood mononuclear cells (PBMCs) were isolated from anti-coagulant-treated whole blood through density gradient centrifugation (Ficoll-Hypaque; TBD Science, Tianjin, China). CD4
1 T cells and CD14 1 monocytes were purified using microbead isolation kits followed by magnetic-activated cell sorting (MACS), according to the manufacturer's instructions (Miltenyi Biotec, Palo Alto,
CA, USA). The purity of the isolated cells, which was determined by flow cytometry (FCM), was greater than 90%. The isolated cells (PBMCs, CD4 1 T cells and monocytes)
were resuspended at a concentration of 1 3 10 6 cells/ml in RPMI 1640 medium (GIBCO-Invitrogen, Carlsbad, CA, USA) containing L-glutamine (2 mM), penicillin/streptomycin (100 U/ml) and 10% fetal calf serum (Gibco-Invitrogen). Immature dendritic cells (iDCs) were generated from monocytes in the presence of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF); 100 ng/ml) and IL-4 (50 ng/ml; PeproTech, London, UK) for 6 days. On day 3, half the culture medium, including GM-CSF and IL-4, was refreshed. For DC maturation, 100 ng/ml lipopolysaccharide (LPS) (Sigma-Aldrich, St Louis, MO, USA) with B2 (5 lM) or the vehicle dimethyl sulphoxide (DMSO) was added to the cells at day 6, and the cells were then cultured for 24 h. CD4
1 T cells were cultured with B2 (5 lM) or the vehicle DMSO in the presence of anti-CD3 [muromonab-CD3 (OKT3), 0Á5 lg/ml] and anti-CD28 antibodies (15E8, 0Á1 lg/ml; Miltenyi Biotec, Auburn, CA, USA) for 3 days. B2-or DMSO-treated DCs were washed three times and then co-cultured with CD4 1 T cells at a ratio of 1 : 5 for 5 days.
Isolation and in-vitro differentiation of mouse CD4 1 T cells Naive CD4 1 T cells were purified from the spleens and lymph nodes of C57BL/6 mice by negative selection using a MACS column (Miltenyi Biotech). The cells were activated with plate-bound anti-CD3 and soluble anti-CD28 (2 lg/ ml) antibodies in RPMI-1640 medium containing 10% fetal bovine serum (FBS), 2 mM glutamine and a 1% penicillin/streptomycin solution for 4 days. The cells were polarized under Th1-polarizing conditions (10 ng/ml IL-12 and 10 lg/ml anti-IL-4 antibody), Th2-polarizing conditions (20 ng/ml IL-4 and 10 lg/ml anti-IFN-g antibody), Th17-polarizing conditions (20 ng/ml IL-6, 5 ng/ml transforming growth factor (TGF)-b, 10 lg/ml anti-IFN-g antibody and 10 lg/ml anti-IL-4 antibody) or T reg -polarizing conditions (5 ng/ml TGF-b and 10 ng/ml IL-2). All cytokines and antibodies used for CD4 1 T cell differentiation were purchased from BD Biosciences (San Jose, CA, USA).
Co-culture of mature DCs and allogeneic
To analyse the ability of DCs matured in the presence of B2 to stimulate allogeneic CD4 1 T cells, the DCs were matured in the presence and absence of B2 and subsequently cultured in the presence of allogeneic CD4 1 T cells for 6 days, as described previously [38] . In short, the DCs were harvested and washed to remove any B2 and then transferred into 96-well round-bottomed tissue culture plates. Freshly isolated CD4 1 T cells were added to the wells, and the cells were co-cultured at a DC : T cell ratio of 1 T cells and DCs were also cultured alone. The effect of the co-culture on T cell and DC activation was analysed by measuring the expression of surface and intracellular molecules by flow cytometry.
MTT assay
Cytotoxicity was assessed using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, as described previously [39] . Briefly, splenocytes (4 3 10 5 cells/well) were cultured in triplicate in a 96-well flat-bottomed plate (Costar, Corning Incorporated, Corning, NY, USA) for 48 h. MTT (5 mg/ml) was added 4 h before the end of the culture, and then solvent [10% sodium dodecyl sulphate (SDS) and 50% N,N-dimethyl formamide, pH 7Á2) was added to dissolve the precipitate. After incubating the solution for 7 h, the optical density (OD) 570 was measured using a microplate reader (Model 550; Bio-Rad).
Proliferation assays
The proliferation of splenocytes in response to convanavalin A (ConA) was determined by [ 3 H]-thymidine uptake, as described previously [39] . Briefly, a BALB/c splenocyte suspension (4 3 10 5 cells/well) was cultured with ConA (5 lg/ml) and irradiated C57BL/6 splenocytes (4 3 10 5 cells/ well) in a 96-well flat-bottomed plate (Costar). The cultures were incubated for 48 h to allow ConA to induce proliferation. The cultures were then treated with 0Á5 lCi 
Mixed lymphocyte reaction (MLR)
To investigate the effect of a series of compounds isolated from the flower of Datura L. on the immune response, we performed an MLR. Mouse T cells were isolated from the spleens and lymph nodes of C57BL/6 and BALB/C mice using a MACS column (Miltenyi Biotech). 
RNA isolation and quantitative real-time polymerase chain reaction (qRT-PCR)
The total RNA from the cells or tissues was isolated using an RNeasy Mini Kit (Qiagen, Valencia, CA, USA), and cDNA was synthesized using the QuantiTect reverse transcription kit (Qiagen). qRT-PCR was performed using the KAPA SYBR Fast qPCR kit (KAPA Biosystems, Woburn, MA, USA), and the results were normalized to the expression of the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The PCR conditions were one cycle at 958C for 5 min, followed by 30-40 cycles at 968C for 20 s, 608C for 20 s and 728C for 20 s, and finally one cycle at 728C for 5 min. The primers used in this experiment were purchased from Qiagen.
Measurement of cytokine production
The cytokine concentrations in the supernatants were determined by enzyme-linked immunosorbent assay (ELISA) (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's protocol. The conditioned media were collected from mouse CD4
1 T cells after differentiation for 4 days or after co-culture with splenocytes for 24 h.
SDS-PAGE and Western blot analysis
The samples were separated by SDS-PAGE and transferred onto polyvinylidene difluoride (PVDF) membranes (Pall Corp., Port Washington, NY, USA). The membranes were blocked for 1 h in blocking buffer (5% skimmed milk in 25 mM Tris-hydrochloric acid (HCl) (pH 8.0), 150 mM sodium chloride (NaCl) and 0Á1% Tween 20) and incubated with specific primary antibodies (Genetex Inc., Irvine, CA, USA) for the target molecules overnight at 48C. The blots were washed and incubated with horseradish peroxidase-conjugated secondary antibodies (Genetex Inc.) for 2 h at room temperature, and the signals were detected using X-ray film following a reaction with an electrochemiluminescence (ECL) detection kit (iNtRON Biotechnology, Korea).
Histological analysis
The histological assessments were performed as described previously [40] . Formalin-fixed, paraffin-embedded ear tissue was sectioned at a thickness of 5 mm and the sections were stained with haematoxylin and eosin (H&E). The following parameters were assessed: (1) the level of leucocyte infiltration and vascular congestion; (2) the erosion and anabrosis of epidermal cells; and (3) the effects on the other side of the ears. The histological scores were assessed from 1 to 4. The final data are the average scores from each animal in the same group, and a higher score indicates more serious inflammation.
Measurement of surface and intracellular molecules by flow cytometry
The purity of CD14
1 monocyte and CD4 1 T cell isolation was confirmed by staining the cells with fluorochromelabelled antibodies against CD14 and CD4, respectively. For analysing the effects of co-culturing DCs and allogeneic CD4 1 T cells, the DCs were stained with fluorochromelabelled antibodies against CD1c, CD40, CD86, CCR7, 
Statistical analysis
The means and standard error of the means were calculated, and the differences between groups were evaluated through one-way analysis of variance (ANOVA) followed by Tukey's post-hoc test when the data were distributed normally. If the data were not distributed normally, one-way ANOVA of ranks followed by Dunn's post-hoc test was used to determine whether the group medians differed, but the means 6 standard errors of the mean (s.e.m.) are listed in the corresponding data tables for clarity. Statistical analyses were performed using SigmaStat version 3.1. A P-value less than 0Á05 was considered statistically significant.
Results
Cytotoxicity of the drugs toward murine splenocytes
We isolated a series of seven withanolides from D. metel flowers, as described in the Materials and methods section. First, we examined the cytotoxic effect of the compounds to identify the safe dose range of the drugs. As shown in Fig. 2a , during a 48-h culture the drugs presented a typical S-shaped concentration-toxicity relationship for murine splenocytes. During a 48-h culture at concentrations up to 1000 mM, the 50% cytotoxic concentration (CC 50 ) value of GB was 59Á03 6 8Á4 mmol; that of B4 was 88Á82 6 9Á8 mmol; that of G1 was 4Á48 6 0Á32 mmol; that of B2 (Fig 1b,  [41] ) was 26Á13 6 4Á65 mmol; that of G6 was 85Á2 6 6Á8 mmol; that of G3 was 6Á39 6 0Á52 mmol; and that of G5 was 7Á01 6 0Á33 mmol (Fig. 2a) . Because GB, B4, B2 and G6 have relatively high CC 50 values, they have a favourably wide safety range. Therefore, we used concentrations of the compounds up to 100 mM in the in-vitro experiments to exclude cytotoxic effects.
Drugs inhibit mitogen-induced murine splenocyte proliferation
A concentration-dependent suppression of murine splenocyte proliferation in response to ConA was observed when the drugs were added to cell cultures. As shown in Fig. 2b , ConA-induced proliferation was inhibited significantly by the drug treatments. The concentration-dependencies were fitted to typical S-shaped curves. In response to ConA, the half-maximal inhibitory concentration (IC 50 ) value of G6 inhibition of lymphocyte proliferation was 20Á50 6 4Á06 mmol/L; the IC 50 of B2 was 46Á21 6 7Á65 mmol/l; the IC 50 of G1 was 71Á98 6 12Á1 mmol/l; the IC 50 of B4 was 9Á007 6 0Á86 mmol/l; the IC 50 of G3 was 6Á788 6 0Á21 mmol/l; the IC 50 of GB was 9Á381 6 0Á67 mmol/l; and the IC 50 of G5 was 26Á83 6 7Á3 mmol/l (Fig. 2b) . Thus, B2, G1, G6 and G5 had low IC 50 values, making these our test compounds.
The drugs suppress CD4 1 T cell differentiation
We performed an MLR using T cells isolated from the spleens and lymph nodes of C57 black 6 (C57BL/6) and BALB/C mice, respectively, to examine the ability of the withanolide compounds isolated from the D. metel flowers to regulate immune responses. Among the seven withanolide compounds, B2 exhibited the strongest inhibitory effect on immune responses (Table 1) . Thus, B2 was selected as the test compound. We then examined the expression of the master transcription factors in mouse CD4
1 T cells cultured under the appropriate polarizing conditions to determine whether B2 could affect CD4 1 T cell differentiation.
The mRNA levels of RORgt, which is the master transcription factor for Th17 cells, was suppressed markedly by treatment with B2, whereas the levels of T-bet and GATA-3, the master transcription factors for Th1 and Th2 cells, respectively, were decreased marginally. In contrast, B2 increased the mRNA levels of FoxP3, the master transcription factor for T reg cells, significantly (Fig. 2c) .
B2 regulates the expression and production of CD4
1
T cell lineage-specific signature cytokines
We next examined the effects of B2 on the expression and production of selected signature cytokines in CD4 1 T cell subsets (IFN-g, IL-4, IL-17A, IL-10 and TGF-b). These cytokines play a critical role in CD4 1 T cell differentiation and are involved in the regulation of master transcription factors [16, 42] . The mRNA levels of Th17 cytokines, such as IL-17A, were decreased substantially; in contrast, the levels of the T reg cytokine IL-10 were increased significantly following treatment with B2 at concentrations greater than 5 mM (Fig. 3a) . Consistent with the mRNA levels, at concentrations greater than 5 mM, B2 inhibited the production of selected Th17 signature cytokines to a greater degree than it inhibited selected Th1 and Th2 signature cytokines when the CD4 1 T cells were polarized under appropriate conditions (Fig. 3b) . Unlike most proinflammatory cytokines, IL-10 is an anti-inflammatory cytokine that plays an important role in maintaining homeostasis and preventing inflammatory responses [43, 44] . We observed that the mRNA levels and production of IL-10 in T reg cells increased following treatment with B2 in a concentration-dependent manner (Fig.  3a,b) . These results suggest that B2 has anti-inflammatory activity by regulating the expression of proinflammatory and anti-inflammatory cytokines during CD4
1 T cell differentiation.
B2 disrupts cytokine-induced JAK/STAT signalling in mouse CD4
1 T cells
The differentiation of CD4 1 T cells is regulated by specific cytokines, and these cytokine-induced signals are associated with the JAK/STAT pathway. Therefore, we investigated whether B2 could affect JAK/STAT signalling in mouse CD4 1 T cells. B2 potently suppressed the IFN-gmediated phosphorylation of STAT-1 and STAT-3 in mouse CD4 1 T cells, which is mediated through a JAK-1-and JAK-2-dependent pathway (Fig. 4a) . Furthermore, the JAK-1-and tyrosine kinase 2 (TYK-2)-dependent phosphorylation of STAT-1 and STAT-4 was suppressed by B2 in IL-12-stimulated mouse CD4 1 T cells (Fig. 4b) . B2 also suppressed IL-4-induced JAK-1-and JAK-3-dependent STAT-6 phosphorylation (Fig. 4c) . The suppressive effects of B2 on several types of cytokine-induced STAT phosphorylation in mouse CD4 1 T cells indicate collectively that B2 can potently suppress JAK/STAT-dependent CD4 1 T cell differentiation.
B2 suppresses cutaneous inflammation in a mouse model
B2 exhibited a broad spectrum of inhibitory effects that included suppression of the JAK/STAT pathway, suggesting that B2 may be effective for the treatment of inflammatory B2 99Á3 6 3Á0 9 3 Á1 6 2Á0 6 0 Á1 6 3Á4 3 2 Á1 6 3Á2 9 Á25 6 1Á2 B4 97Á4 6 3Á2 9 0 Á9 6 3Á0 5 1 Á9 6 2Á0 2 6 Á2 6 2Á0 1 0 Á55 6 2Á5 G1 95Á7 6 3Á4 7 0 Á3 6 2Á2 4 6 Á4 6 5Á0 7 Á1 6 2Á7 1 5 Á7 6 2Á3 GB 99Á1 6 4Á4 6 3 Á3 6 6Á0 1 8 Á1 6 2Á1 -1 9 Á41 6 2Á7 G3 98Á9 6 3Á1 7 8 Á7 6 2Á9 3 4 Á6 6 5Á7 7 Á5 6 3Á4 1 4 Á83 6 1Á9 G4 67Á6 6 3Á3 4 6 Á5 6 6Á0 2 6 Á1 6 3Á3 1 2 Á5 6 2Á5 2 7 Á6 6 2Á7 G5 98Á2 6 3Á5 7 6 Á3 6 4Á0 2 0 Á4 6 4Á4 6 Á8 6 3Á5 1 6 Á49 6 2Á1 and immune disorders. Inflammation was induced in mouse ears via intradermal injection of IL-23 to examine the in-vivo effects of B2 in a well-designed animal model.
IL-23 is a proinflammatory cytokine that plays an important role in inflammatory autoimmune diseases, such as psoriasis and rheumatoid arthritis, by inducing Th17 Fig. 3 . B2 inhibits the expression and production CD4 1 T cell-specific signature cytokines. (a) Total RNA was prepared from T cells differentiated using the conditions described in Fig. 2c , and quantitative real-time polymerase chain reaction (qRT-PCR) was performed. (b) Cultured media were collected from T cells that had been differentiated using the conditions described in Fig. 2c . The cytokine concentrations were analysed by enzyme-linked immunosorbent assay (ELISA). *P < 0Á001 and **P < 0Á05 versus the differentiated groups. cell-derived cytokine-mediated activation of the STAT-3 signalling pathway [42, [45] [46] [47] . The intradermal injection of IL-23 into the ears of mice clearly increased ear swelling compared with the PBSinjected control group, which is the first hallmark of local skin inflammation (Fig. 5a) . In addition, a of H&E-stained sections revealed epidermal hyperplasia, hyperkeratosis and increased dermal inflammatory cell infiltration compared with the PBS-injected mice. In contrast to PBS-injected mice, the administration of B2 resulted in a significant decrease in IL-23-induced epidermal hyperplasia (indicated by acanthosis) and dermal inflammatory infiltrates in mice (Fig. 5b-d) . Topical application of B2 on the ear skin of the mice decreased ear swelling and all pathological signs of inflammation effectively (Fig. 5a,b) . These results indicate that B2 might be able to modulate cutaneous inflammation in diseases, such as psoriasis and contact dermatitis.
Withasteroid regulates immune responses
B2 suppresses the expression of proinflammatory mediators in mouse ears induced by cutaneous inflammation
During inflammatory responses, the expression levels of proinflammatory mediators are increased, and prolonged expression and production of these inflammatory mediators induce a number of inflammatory diseases. Because B2 suppressed the IL-23-induced progression of cutaneous inflammation in mouse ears, we performed a qRT-PCR analysis using mouse ears to assess the mRNA levels of proinflammatory mediators. Similar to the histological changes, the quantitative qRT-PCR analysis showed that the mRNA levels of T cell-specific cytokines were elevated in the IL-23-injected mouse ears, whereas B2 decreased these mRNA levels and the mRNA levels of IFNg, IL-17A and IL-22 effectively, which are Th1 and Th17 cell lineage-specific signature cytokines, to a greater degree than it decreased the Th2 cell signature cytokine IL-4 ( Fig. 6a) . This result is consistent with the results of the CD4 1 T cell differentiation assay. Furthermore, treatment with B2 decreased effectively the mRNA levels of inflammatory cytokines and chemokines that are known to play a major role in psoriasis, such as chemokine (C-X-C motif) ligand 1 (CXCL1), activation-regulated chemokine ligand (CCL)17, CCL20, CCL27 and CC chemokine receptor (CCR) 6, and a number of inflammatory mediators, such IL-1a, IL-1b, IL-6, TNF-a and cyclooxygenase (COX)-2 ( Fig. 6b) . In contrast, the mRNA levels of an antiinflammatory cytokine, IL-10, in mouse ears were increased significantly following treatment with B2 (Fig.  6b) . These results suggest clearly that B2 modulates cutaneous inflammation in diseases, such as psoriasis and contact dermatitis, by regulating CD4 1 T cell differentiation and the complex network of cytokine-mediated signalling cascades.
Ability of B2 to reduce the RORgt
IL-10
1 ratio in CD4 1 T cells reduced when the cells were co-cultured with B2 compared with that of those cultured without B2 (Fig. 7a) , indicating that B2 hampers the differentiation of Th17 cells. In addition, a higher proportion of allogeneic CD4 1 T cells expressing FoxP3 and IL-10 was found in the co-culture system with B2 compared with that observed in the coculture without B2 (Fig. 7a) , suggesting that B2 enhances T reg differentiation. This difference in expression resulted in a decreased ratio of allogeneic CD4 1 T cells expressing
RORgt and IL-17 to those expressing FoxP3 and IL-10 when the cells were co-cultured with B2 compared with the ratio obtained in the co-culture without B2 (Fig. 7b) .
Discussion
Psoriasis, a chronic skin disease, is known to be the most prevalent autoimmune disease in humans. The precise aetiology of psoriasis remains poorly understood, but is thought to result from immune dysfunction [46] . [16, 47] . Our study showed that B2 affected the expression and production of Th cell lineage-specific master transcription factors and cytokines. Of the master transcription factors, T-bet (the Th1 master regulator) and RORgt (the Th17 master regulator) were more susceptible to B2 than the Th2 master transcription factor GATA-3, and these inhibitory effects were correlated with the mRNA levels and production of Th cell lineage-specific cytokines. In addition, B2 increased the mRNA levels of FoxP3 significantly (the T reg master transcription factor), as well as the cell lineage-specific cytokines. In general, Th1 cells are known to be involved in organ-specific autoimmunity, Th17 cells are involved in systemic autoimmune diseases and cancers and T reg cells are responsible for immunosuppressive activities by producing their specific cytokines [12, 48] . The inhibitory effect of B2 on CD4 1 T cell differentiation suggests that this compound may ameliorate various immune-related diseases that are caused by an aberrantly regulated immune response, particularly diseases in which the pathology is mediated by Th1 and Th17 cells rather than Th2 cells, such as psoriasis.
Psoriasis is a T cell-mediated skin disorder that is accepted to be mediated mainly by Th17 cells [47, 49] , but has also been associated with dysfunctional T regs [11] . We studied the effects of co-culturing allogeneic CD4 [12] .
The development of psoriasis is known to be associated with STAT-3 activation, which is necessary for Th17 cell development and is activated by cytokines [48, 50] . In addition, inhibition of STAT-3 activation by treatment with a STAT-3 inhibitor in a mouse model and in psoriasis patients provided effective therapeutic activities in psoriatic lesions [51] . In addition to inhibiting the expression of Th17 and T reg cell lineage-specific master transcription factors and cytokines, B2 also effectively inhibited cytokineinduced activation of the STAT proteins STAT-1, STAT-3, STAT-4, STAT-5 and STAT-6. The JAK/STAT signalling pathway transduces cytokine-mediated signals, and STAT proteins are important transcription factors in CD4
1 T cell differentiation [16, 42] . Activation of the JAK/STAT signalling cascade in abnormal conditions is associated with a wide range of inflammatory diseases and cancers. Therefore, regulation of the aberrantly activated JAK/STAT signalling cascade is a valuable therapeutic target for the treatment of human diseases, including psoriasis. Thus, the inhibitory activity of B2 on CD4 1 T cell differentiation was mediated by its combined regulatory effects on multiple signalling cascades at multiple levels, including the expression of master transcription factors, the production and expression of T cell lineage-specific cytokines, and the cytokine-induced activation of STAT proteins. Our results indicate that STAT-3 is one of the important factors in the development of psoriasis and that B2 might be used as a possible therapeutic small molecule for the treatment of autoimmune diseases, including psoriasis.
We further investigated whether B2 could inhibit IL-23-induced psoriasis-like skin inflammation in mice to determine the effect of B2 in vivo. In this model, IL-23 induces skin inflammation by triggering the infiltration of mononuclear cells into the epidermis and dermis, followed by Th17 cell differentiation and STAT-3 signalling pathway activation [37, [52] [53] [54] . We observed that B2 ameliorated the cutaneous inflammatory responses in this model by inhibiting the expression of various proinflammatory mediators. These results suggest that B2 may ameliorate inflammation in chronic skin inflammatory diseases by suppressing pathogenic CD4
1 T cell differentiation and the overall immune response.
In summary, we observed that B2, which was isolated from D. metel L. flowers, strongly inhibited CD4 1 T cell differentiation and immune responses by regulating JAK/ STAT signaling and the development of psoriasis-like skin diseases in an animal model. Moreover, B2 decreased the IL-17
1 RORgt 1 /IL-10 1 FoxP3 1 ratio in co-cultures of CD4 1 T cells with DC-B2. These results provide new evidence that B2 might ameliorate CD4
1 T cell-mediated inflammatory skin diseases, implying that it is a promising candidate treatment for immune cell-mediated skin inflammatory diseases.
Some limitations of this study should be addressed. First, our study used animal models of IL-23-induced psoriasis, and although this model shares many characteristics with human psoriasis, the causes of psoriasis are still unclear. Thus, research studies using mice with imiquimod-induced dermatitis, transgenic mice, or a severe combined immunodeficiency disease (SCID) mouse psoriasis skin xenograft model, which develops a psoriasislike skin disease, are necessary to confirm the immune efficacy of B2. Secondly, we hypothesized that the use of B2 alone might not completely inhibit the symptoms. Thus, the treatment of psoriasis should comprise a combination therapy with other withasteroids isolated from D. metel L. Further studies are needed to evaluate the efficacy of combination therapies.
